ADAMTSL4 | ADAMTS-like 4 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | | | Tissue enhanced |
BIRC7 | Baculoviral IAP repeat containing 7 | | | | | | Tissue enhanced |
CCSAP | Centriole, cilia and spindle-associated protein | | | | | | Tissue enhanced |
COL15A1 | Collagen, type XV, alpha 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COLEC12 | Collectin sub-family member 12 | Predicted membrane proteins
| | | | | Tissue enhanced |
CTHRC1 | Collagen triple helix repeat containing 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
EFHD1 | EF-hand domain family, member D1 | | | | | | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ENDOU | Endonuclease, polyU-specific | Predicted secreted proteins
| | | | | Tissue enhanced |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
GDF15 | Growth differentiation factor 15 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GJA5 | Gap junction protein, alpha 5, 40kDa | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GLDN | Gliomedin | | | | | | Tissue enhanced |
HAPLN1 | Hyaluronan and proteoglycan link protein 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
HES2 | Hes family bHLH transcription factor 2 | Transcription factors
| | | | | Tissue enhanced |
HLA-G | Major histocompatibility complex, class I, G | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
HTRA1 | HtrA serine peptidase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
IDO1 | Indoleamine 2,3-dioxygenase 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
LYPD6 | LY6/PLAUR domain containing 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
MFAP5 | Microfibrillar associated protein 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
PDPN | Podoplanin | Predicted membrane proteins
| | | | | Tissue enhanced |
PEG10 | Paternally expressed 10 | | | | | | Tissue enhanced |
PEG3 | Paternally expressed 3 | Transcription factors
| | | | | Tissue enhanced |
PKIB | Protein kinase (cAMP-dependent, catalytic) inhibitor beta | | | | | | Tissue enhanced |
PTGES | Prostaglandin E synthase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
REN | Renin | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SPTLC3 | Serine palmitoyltransferase, long chain base subunit 3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
STS | Steroid sulfatase (microsomal), isozyme S | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
TFAP2A | Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | Disease related genes Transcription factors
| | | | | Tissue enhanced |
TFAP2C | Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | Transcription factors
| | | | | Tissue enhanced |
TINAGL1 | Tubulointerstitial nephritis antigen-like 1 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
UBASH3B | Ubiquitin associated and SH3 domain containing B | Enzymes
| | | | | Tissue enhanced |